Apogee Therapeutics, Inc. (APGE)
76.10
+1.36
(+1.82%)
USD |
NASDAQ |
Dec 10, 16:00
76.10
0.00 (0.00%)
After-Hours: 16:06
Apogee Therapeutics EPS Diluted (Quarterly): -1.106 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Nektar Therapeutics | -1.875 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Aveanna Healthcare Holdings, Inc. | 0.0633 |
| Turn Therapeutics, Inc. | -0.068 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -65.02M |
| Total Expenses (Quarterly) | 65.02M |
| Enterprise Value | 4.589B |
| Earnings Yield | -5.67% |
| Normalized Earnings Yield | -5.675 |